📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

RuvBL1/2 reduce toxic dipeptide repeat protein burden in multiple models of C9orf72-ALS/FTD. (2025)

First Author: Webster CP

Attributed to: Gene Therapy Innovation and Manufacturing Centre (GTIMC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202402757

PubMed Identifier: 39638345

Publication URI: http://europepmc.org/abstract/MED/39638345

Type: Journal Article/Review

Volume: 8

Parent Publication: Life science alliance

Issue: 2

ISSN: 2575-1077